Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company manufacturers of macrolides and anti-TB products such as pharma formulations, distribution and logistics.
Anuh Pharma Limited, is an unlisted public company incorporated on 19 February, 1960. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 51.00 cr and the total paid-up capital is INR 25.06 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
8.39%
9.45%
18.38%
12.84%
-100.0%
16.65%
1.5
0.09
0.57
0.7
2.44
-0.01
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(6)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 1
Total Amount : 95.0 cr
Canara Bank
No. of Loans: 1
Total Amount : 0.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Siddharth Shah Jasvantlal | 00004958 | 1 years |
| Director | Arun Lalchand Todarwal
Shareholder
|
00020916 | 16 years |
| Director | Bipin Nemchand Shah
Shareholder
|
00083244 | 16 years |
| Director | Ketan Lalit Shah
Shareholder
|
00083326 | 8 years |
| Director | Bharat Nemchand Shah
Shareholder
|
00083354 | 44 years |
| Director | Samir Jayantilal Shah
Shareholder
|
00157396 | 8 years |
| Director | Pradeep Hari Thakur | 00685992 | 1 years |
| Kmp | Ritesh Bipin Shah | <HIDDEN> | 9 years |
| Managing Director | Ritesh Bipin Shah
Shareholder
|
02496729 | 8 years |
| Director | Gaurav Satish Shah | 02878186 | 1 years |
| Kmp | Vivek Bipin Shah | <HIDDEN> | 9 years |
| Managing Director | Vivek Bipin Shah
Shareholder
|
02878724 | 8 years |
| Director | Harmanbhai Tulshibhai Patel | 07342390 | 6 years |
| Director | Mita Dixit
Shareholder
|
08198165 | 6 years |
| CFO | Darshan Rampariya | <HIDDEN> | 11 years |
| Kmp | Manan Jayesh Vadhan | <HIDDEN> | 1 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| JASVI CAPITAL PRIVATE LIMITED |
Active
|
2.2 Cr | 1 | Maharashtra |
| J G A SHAH SHARE BROKERS PRIVATE LIMITED |
Active
|
1.1 Cr | 1 | Maharashtra |
| AMANECER CAPITAL PARTNERS LLP |
Active
|
5.0 L | 1 | Maharashtra |
| AES TRADING AND CONSULTANTS LLP |
Active
|
50,000.0 | 1 | Maharashtra |
| NESCO LIMITED |
Active
|
14.1 Cr | 1 | Maharashtra |
| WELSPUN GLOBAL BRANDS LIMITED |
Amalgamated
|
10.5 Cr | 1 | Gujarat |
| LAKECITY VENTURES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| LAXMI ORGANIC INDUSTRIES LIMITED |
Active
|
55.3 Cr | 1 | Maharashtra |
| PTC CABLES PVT LTD |
Active
|
27.4 L | 1 | West Bengal |
| WELSPUN TRANSFORMATION SERVICES LIMITED |
Active
|
3.0 Cr | 1 | Gujarat |
| ARUN TODARWAL & ASSOCIATES LLP |
Active
|
1.0 L | 1 | Maharashtra |
| ARUN TODARWAL & CO LLP |
Active
|
1.0 L | 1 | Maharashtra |
| STERLITE POWER GRID VENTURES LIMITED |
Amalgamated
|
1,543.7 Cr | 1 | Maharashtra |
| UNICHEM LABORATORIES LIMITED |
Active
|
14.1 Cr | 1 | Maharashtra |
| BHARAT FIH LIMITED |
Active
|
2,380.9 Cr | 1 | Tamil Nadu |
| SINTEX-BAPL LIMITED |
Active
|
11.4 L | 1 | Gujarat |
| CHAITANYA LIFE SCIENCE PRIVATE LIMITED |
Active
|
1.5 Cr | 3 | Gujarat |
| ITAL PHARCHEM PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| ESKAY IODINE PRIVATE LIMITED |
Active
|
4.0 Cr | 3 | Maharashtra |
| MALABAR HILL CLUB LIMITED |
Active
|
0.0 | 1 | Maharashtra |
| L P SHAH HOLDINGS AND TRADES PVT LTD |
Converted to LLP and Dissolved
|
1.2 L | 1 | Maharashtra |
| L P SHAH HOLDINGS AND TRADES LLP |
Active
|
1.2 L | 1 | Maharashtra |
| PRAGATI PHARMA PRIVATE LIMITED |
Converted to LLP
|
12.0 L | 2 | Maharashtra |
| S KANT CHEMICALS PRIVATE LIMITED |
Active
|
1.0 L | 3 | Maharashtra |
| S KANT HEALTHCARE LIMITED |
Active
|
98.0 L | 4 | Maharashtra |
| JAPOSHA TRADING PRIVATE LIMITED |
Converted to LLP
|
1.2 L | 1 | Maharashtra |
| ASHOK GNXT PHARMA PRIVATE LIMITED |
Active
|
1.0 L | 1 | Gujarat |
| S KANT INDIA PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| SKITES RETAIL PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| JAPOSHA TRADING LLP |
Active
|
1.2 L | 1 | Maharashtra |
| SHROFF PHARMA LLP |
Active
|
1.0 L | 1 | Maharashtra |
| SEVANTILAL KANTILAL PRIVATE LIMITED |
Active
|
12.0 L | 1 | Maharashtra |
| SKITES PHARMA PRIVATE LIMITED |
Active
|
5.9 Cr | 1 | Maharashtra |
| INDO AMINES LIMITED |
Active
|
35.3 Cr | 1 | Maharashtra |
| WILTEK CARE LLP |
Active
|
1.0 L | 1 | Maharashtra |
| AARTI PHARMALABS LIMITED |
Active
|
45.3 Cr | 1 | Gujarat |
| LEWENS LABS PRIVATE LIMITED |
Active
|
2.6 Cr | 1 | Gujarat |
| SHETRON LIMITED |
Active
|
9.0 Cr | 1 | Karnataka |
| EQUATIONS ADVISORS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| PROLIFIC RESOLUTION PRIVATE LIMITED |
Active
|
10.2 L | 1 | Rajasthan |
| HINDUSTAN CONSTRUCTION COMPANY LIMITED |
Active
|
168.0 Cr | 1 | Maharashtra |
The incorporation date of ANUH PHARMA LIMITED is 19 February, 1960
The authorized share capital of ANUH PHARMA LIMITED is INR ₹ 51.0 Cr.
The paid-up capital of ANUH PHARMA LIMITED is INR ₹ 25.1 Cr.
The registered address of ANUH PHARMA LIMITED is A 3 SHIV SAGAR ESTATEDR ANNIE BESANT ROAD MUMBAI Maharashtra - 400018
The CIN number of ANUH PHARMA LIMITED is L24230MH1960PLC011586.
Expand
Delete
Collapse
See
details
